|
|
| | (ARG6,D-TRP7,9,N-ME-PHE8)-SUBSTANCE P (6-11) Basic information |
| Product Name: | (ARG6,D-TRP7,9,N-ME-PHE8)-SUBSTANCE P (6-11) | | Synonyms: | H-ARG-D-TRP-N-ME-PHE-D-TRP-LEU-MET-NH2;(ARG6,D-TRP7,9,N-ME-PHE8)-SUBSTANCE P (6-11);ARG-D-TRP-N-ME-PHE-D-TRP-LEU-MET-NH2;ANTAGONIST G;arginyl-tryptophyl-n-methylphenylalanyl-tryptophyl-leucyl-methioninamide;(arg6;Substance P, fragment 6-11, [Arg6, D-Trp7,9, NMePhe8];[Arg6, D-Trp7,9, N-Me-Phe8]-SubstanceP fragment6-11 | | CAS: | 115150-59-9 | | MF: | C49H66N12O6S | | MW: | 951.19 | | EINECS: | | | Product Categories: | Peptide | | Mol File: | 115150-59-9.mol |  |
| | (ARG6,D-TRP7,9,N-ME-PHE8)-SUBSTANCE P (6-11) Chemical Properties |
| RTECS | PC4360070 | | storage temp. | -15°C | | form | Solid | | color | Off-white to light yellow | | Water Solubility | Soluble to 1mg/ml in water |
| | (ARG6,D-TRP7,9,N-ME-PHE8)-SUBSTANCE P (6-11) Usage And Synthesis |
| Uses | Antagonist G is an anticancer agent, which modulates gastrin releasing peptide (GRP) and arginine vasopressin signalling in small cell lung cancer cells leading to growth arrest and apoptosis. |
| | (ARG6,D-TRP7,9,N-ME-PHE8)-SUBSTANCE P (6-11) Preparation Products And Raw materials |
|